Clinical trial
Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
NCT00004893 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00004893 |
|---|---|
| Title | Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer |
| Official title | Evaluation of Novel Therapeutic Agents Against Breast Cancer: An Innovative Randomized Phase II Trial Design |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological |
| Interventions | recombinant interleukin-12 |
| Enrollment | 5 |
| Start date | Dec 1, 1999 |
| Primary completion | Feb 1, 2002 |
| Completion | Feb 1, 2002 |
| First posted | May 3, 2004 |
| Last update posted | Jul 19, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: